Search for: "Glaxosmithkline LLC" Results 21 - 40 of 182
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Justices asked to strengthen the right to earn a living
29 Jul 2022, 6:11 pm by Kalvis Golde
GlaxoSmithKline, LLC 22-37Issue: Whether a generic drug manufacturer’s FDA-approved label that carves out all of the language the brand manufacturer has identified as covering its patented uses can be held liable on a theory that its label still intentionally encourages infringement of those carved-out uses. [read post]
SCOTUSblog - http://www.scotusblog.com/
Inducing Infringement with the Skinny Label
17 Jul 2022, 5:00 am by Dennis Crouch
GlaxoSmithKline LLC, SCT Docket No. 22-37 (2022). [read post]
Patently-O - https://patentlyo.com
Skinny Label Safe Harbor
6 May 2022, 8:10 am by Dennis Crouch
Cir. 2021), en banc denied at GlaxoSmithKline LLC v. [read post]
Patently-O - https://patentlyo.com
Induced Infringement and the Section 286 Statute of Limitations
10 Apr 2022, 12:58 pm by Holman
Meso Scale Diagnostics, LLC, 2022 WL 1052320, — 4th —  (Fed. [read post]
Patently-O - http://patentlyo.com/patent
Brief of 14 Professors of Law as Amici Curiae in Support of the Petition for Rehearing En Banc in GlaxoSmithKline v. Teva Pharmaceuticals, Fed. Cir. No. 18-1976
28 Feb 2022, 2:00 am by Katharine Van Tassel
No. 18-1976, SSRN (2021): In GlaxoSmithKline LLC v. [read post]
Health Law Prof Blog - http://lawprofessors.typepad.com/healthlawprof_blog/
GlaxoSmithKline LLC v. Teva Pharmnaceuticals USA (Fed. Cir. 2022)
15 Feb 2022, 9:03 pm by Patent Docs
Federal Circuit Denies En Banc Review in GlaxoSmithKline LLC v. [read post]
Patent Docs - http://www.patentdocs.org/
Can Equitable Estoppel Save Skinny Labels?
14 Feb 2022, 9:38 am by Dennis Crouch
by Dennis Crouch GlaxoSmithKline LLC v. [read post]
Patently-O - http://patentlyo.com/patent
Legal Intelligencer: Qui Tam Suits and Veil Piercing: A Powerful Combo for Combating Health Care Fraud
4 Nov 2021, 7:03 pm by Edward T. Kang and Ryan T. Kirk
The health care industry is no longer limited to doctors and hospitals, but a veritable thicket of holding companies, LLCs, and private equity firms. [read post]
Kang Haggerty Firm News. - https://www.khflaw.com/news/
How Public Opinion Polls Expand the Conversation on GSK v. Teva and Skinny Labeling
14 Oct 2021, 4:15 am by Gretchen Miller
The Federal Circuit’s recent majority opinion and Chief Judge Prost’s dissenting opinion in the GlaxoSmithKline LLC v. [read post]
IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com
How Public Opinion Polls Expand the Conversation on GSK v. Teva and Skinny Labeling
14 Oct 2021, 4:15 am by Gretchen Miller
The Federal Circuit’s recent majority opinion and Chief Judge Prost’s dissenting opinion in the GlaxoSmithKline LLC v. [read post]
IPWatchdog - http://www.ipwatchdog.com/
Carve outs and Causation: Moving Away From Hypothetical Hatch-Waxman Infringement
24 Aug 2021, 2:10 am by Charlotte Jacobsen (Ropes & Gray LLP), Filko Prugo (Ropes & Gray LLP) and James Stevens (Ropes & Gray LLP)
Teva GlaxoSmithKline LLC v. [read post]
Kluwer Patent Blog - http://patentblog.kluweriplaw.com/
reasonable consumer isn't required to interpret ingredient list for naturalness
13 Aug 2021, 6:43 am by Rebecca Tushnet
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, No. 20-cv-09077-JSW,  2021 WL 3524047 (N.D. [read post]
43(B)log - http://tushnet.blogspot.com/
GlaxoSmithKline LLC v. Teva Pharmaceuticals USA (Fed. Cir. 2021)
12 Aug 2021, 8:59 pm by Patent Docs
By Kevin E. [read post]
Patent Docs - http://www.patentdocs.org/
Teva loses in GSK case; infringement found in case involving carvedilol for treatment of hypertension and congestive heart failure (CHF)
5 Aug 2021, 12:12 pm by Lawrence B. Ebert
GlaxoSmithKline LLC v. [read post]
IPBiz - http://ipbiz.blogspot.com/
CAFC reviews D.N.J. on ticks and confidentiality agreements; plaintiff wins on misappropriation but loses on infringement
14 Jul 2021, 8:09 pm by Lawrence B. Ebert
The background of the opinion describes the rather complex set of issues: We describe the facts in the light most favorable to the party that won the jury verdict (here, the plaintiffs). [read post]
IPBiz - http://ipbiz.blogspot.com/
CAFC Denies Amgen Petition to Reconsider Enablement Test for Biotech Patents
25 Jun 2021, 4:15 am by Logan Murr
LLC (Sanofi). [read post]
IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com
Guest Post: The Open Source Hardware Association’s Perspective on GSK v. Teva
16 Mar 2021, 6:00 am by Jason Rantanen
To the Open Source Hardware (OSHW) community, the Federal Circuit’s October opinion in the ongoing appeal of GlaxoSmithKline LLC v. [read post]
Patently-O - http://patentlyo.com/patent
Skinny-labels; Carveouts; and Inducing Infringement
10 Feb 2021, 7:12 pm by Dennis Crouch
GlaxoSmithKline LLC v. [read post]
Patently-O - http://patentlyo.com/patent
Federal Circuit Agrees to Reconsider Ruling in GSK v. Teva Drug Patent Case
10 Feb 2021, 8:54 am by Evan Sumner, Jesse Salen and Bradley Graveline
The case is GlaxoSmithKline LLC v. [read post]
Intellectual Property Law Blog - http://www.intellectualpropertylawblog.com/
Has the Federal Circuit Made It Nearly Impossible to Maintain Genus Claims?
26 Jan 2021, 8:11 am by Tina G. Yin Sowatzke, Pharm.D.
Amgen, GlaxoSmithKline (GSK) and a group of intellectual property professors filed a trio of amicus briefs placing their support behind Idenix, warning that the future of innovation was on the line. [read post]
Filewrapper.com - https://www.filewrapper.com/